» Articles » PMID: 32108102

Artificial Intelligence in Cancer Therapy

Overview
Journal Science
Specialty Science
Date 2020 Feb 29
PMID 32108102
Citations 43
Authors
Affiliations
Soon will be listed here.
Citing Articles

Personalized dose selection platform for patients with solid tumors in the PRECISE CURATE.AI feasibility trial.

Blasiak A, Truong A, Foo N, Tan L, Kumar K, Tan S NPJ Precis Oncol. 2025; 9(1):49.

PMID: 39984618 PMC: 11845749. DOI: 10.1038/s41698-025-00835-7.


Integrating AI into Cancer Immunotherapy-A Narrative Review of Current Applications and Future Directions.

Olawade D, Clement David-Olawade A, Adereni T, Egbon E, Teke J, Boussios S Diseases. 2025; 13(1).

PMID: 39851488 PMC: 11764268. DOI: 10.3390/diseases13010024.


The role of artificial intelligence in immune checkpoint inhibitor research: A bibliometric analysis.

Zhao Z, Xu K, Jiang Y, Xu X, Liu Y Hum Vaccin Immunother. 2024; 20(1):2429893.

PMID: 39610043 PMC: 11610551. DOI: 10.1080/21645515.2024.2429893.


Personalized dose selection for the first Waldenström macroglobulinemia patient on the PRECISE CURATE.AI trial.

Blasiak A, Tan L, Chong L, Tadeo X, Truong A, Senthil Kumar K NPJ Digit Med. 2024; 7(1):223.

PMID: 39191913 PMC: 11350179. DOI: 10.1038/s41746-024-01195-5.


Artificial Intelligence as a Potential Catalyst to a More Equitable Cancer Care.

Garcia-Saiso S, Marti M, Pesce K, Luciani S, Mujica O, Hennis A JMIR Cancer. 2024; 10:e57276.

PMID: 39133537 PMC: 11347894. DOI: 10.2196/57276.